Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
11/2001
11/08/2001US20010039443 Method for collecting data pertinent to predictors of heart arrhythmias using an animal test subject
11/08/2001US20010038837 Introducing non-tumorogenic skeletal myoblasts or cardiomyocytes in myocardial tissue of the animal so as to form a stable myocardial graft, can be used, to deliver recombinant proteins directly to the heart
11/08/2001US20010038834 A therapeutic agent, comprising a bone marrow cell which has been transfected with DNA operably connected to a promoter, which DNA encodes the expression of antitumer agent when introduced into a mammal, homes to bone marrow of the mammal
11/08/2001CA2407834A1 Method of identifying agents that alter the activity of the promoter sequence for corticotropin releasing-factor receptor crf 2-alpha
11/08/2001CA2407737A1 Regulatory nucleic acid for the abc1 gene, molecules modifying its activity and therapeutic uses
11/08/2001CA2407435A1 Rna metabolism proteins
11/08/2001CA2406999A1 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners
11/07/2001EP1151109A1 Fucosyl transferase gene
11/07/2001EP1151099A1 Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy
11/07/2001EP1151092A1 Inhibiting formation of atherosclerotic lesions
11/07/2001EP1151010A2 Human polyclonal antibodies from transgenic nonhuman animals
11/07/2001EP1151001A2 Method for altering undesirable immune responses to polypeptides
11/07/2001EP0986635A4 Embryonic stem cell serum replacement
11/07/2001EP0907726A4 Chromosomal rearrangement by insertion of two recombination substrates
11/07/2001CN1320426A Compound for treatment of female sexual dysfuction
11/06/2001US6313373 Tissue specific promoters and transgenic mouse for the screening of pharmaceuticals
11/06/2001US6313280 Suppresses brachyury-mediated transcription activation; hybrid screening assays; zinc finger domains; genetic engineering and expression
11/06/2001US6312907 An isolated nucleic acid encoding a gene for decorin binding protein from borrelia; diagnosis and therapy of lyme disease in humans and animals
11/06/2001US6312898 Diagnosing and treating subjects having increased risk for the development of the disease using polymerase chain reaction and/or sequencing methods to determine amino acid polymorphism in the protein
11/01/2001WO2001081540A2 Growth factor which acts through erb b-4 rtk
11/01/2001WO2001081413A2 Isolated human transporter proteins, nucleic acids and uses thereof
11/01/2001WO2001080873A2 Thrombopoietin receptor modulating peptide
11/01/2001WO2001080633A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
11/01/2001WO2001080632A1 Cell and nonhuman animal capable of amplifying hcv
11/01/2001WO2001036604A3 Nucleic acids encoding endotheliases, endotheliases and uses thereof
11/01/2001WO2001029204A3 Protein production system
11/01/2001US20010037513 Method for cloning animals with targetted genetic alterations by transfer of long-term cultured male or female somatic cell nuclei, comprising artificially-induced genetic alterations, to enucleated recipient cells
11/01/2001US20010036919 Preventing airway mucus production by administration of EGF-R antagonists
11/01/2001CA2407167A1 Thrombopoietin receptor modulating peptide
11/01/2001CA2407084A1 Isolated human transporter proteins, nucleic acids and uses thereof
10/2001
10/31/2001EP1149906A1 Thrombopoietin receptor modulating peptide
10/31/2001EP1149899A1 Culture medium for avian totipotential embryonic cells
10/31/2001EP1149114A2 Polypeptides involved in immune response
10/31/2001EP1148779A2 Expression of secreted human alpha-fetoprotein in transgenic animals
10/30/2001US6310045 Compositions and methods for cancer immunotherapy
10/30/2001US6310034 Agouti polypeptide compositions
10/30/2001US6309876 Expression vector for propagation of cells in nervous system; for treating nervous system damage; gene therapy
10/30/2001US6309863 Immunizing an animal with the synthetic polypeptide which isa mimetic of the particular amino acid and is phosphorylated, collecting serum or ascitic fluid from immunized animal, screening for presence of antibodies specific for polypeptide
10/30/2001US6309848 Screening for microbiocides; provide cells, human vaginal graft, bactericide and parasite, graft tissue in host cavity, expose to bactericide, inoculate graft with parasite, test for presence of parasite
10/30/2001US6309645 A method of suppressing an immune response in a mammal.
10/30/2001US6309638 Netrins
10/25/2001WO2001079525A2 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
10/25/2001WO2001079468A2 Drug metabolizing enzymes
10/25/2001WO2001079452A2 Tolerance-inducing thy-marrow composite tissue construct and organ
10/25/2001WO2001079448A2 Trp8, a transient receptor potential channel expressed in taste receptor cells
10/25/2001WO2001079445A2 Pluripotent cells comprising allogenic nucleus and mitochondria
10/25/2001WO2001078796A1 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor
10/25/2001WO2001050880A3 Cultivation of dha-rich prey organisms for aquatic species
10/25/2001WO2001039786A3 New uses of suppressive macrophage activation factors
10/25/2001WO2001022092A3 Method to identify compounds which modulate fra-1 expression fils
10/25/2001WO2001022091A3 Method for determining the fertility of mammals, especially of humans
10/25/2001WO2000047618A9 HUMAN β-SECRETASE ENZYME, INHIBITORS AND THEIR COMPOSITIONS AND USES
10/25/2001US20010034884 Abeta-peptide screening assay
10/25/2001US20010034024 Mutations in and genomic structure of HERG - a long QT syndrome gene
10/25/2001CA2406481A1 Trp8, a transient receptor potential channel expressed in taste receptor cells
10/25/2001CA2405555A1 Pluripotent cells comprising allogenic nucleus and mitochondria
10/25/2001CA2404127A1 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor
10/25/2001CA2403644A1 Drug metabolizing enzymes
10/25/2001CA2403547A1 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
10/24/2001EP1147413A2 Growth differentiation factor inhibitors and uses therefor
10/24/2001EP1147185A2 Mammal, method for producing same and its use
10/24/2001EP1147174A1 Desaturases and methods of using them for synthesis of polyunsaturated fatty acids
10/24/2001EP1147137A1 Methods for generating phosphorylation site-specific immunological reagents
10/24/2001EP1147136A1 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF
10/24/2001EP1147134A1 Novel potassium channels and genes encoding these potassium channels
10/24/2001EP1147123A2 Novel odorant receptors in drosophila
10/24/2001EP1146892A2 Baff, inhibitors thereof and their use in the modulation of the b-cell response
10/24/2001CN2455069Y Automatic maggot-feeding apparatus
10/24/2001CN1318289A Transgenic silkworm screening method
10/23/2001US6307122 Immunologicaly defective rodent; for monitoring viral infection in preferential tissue; for the treatment of tumors and autoimmune diseases
10/23/2001US6307121 Bacteriophage-based transgenic fish for mutation detection
10/23/2001US6306831 Transplacental delivery of oligonucleotides
10/23/2001US6306651 Bone marrow hematopoietic stem cell; for use in prevention of graft versus host disease
10/23/2001US6306586 Methods and compositions for the diagnosis and treatment of cataracts
10/23/2001US6306581 Diagnostic assay method and kit for the detection of HHV-8 infection
10/23/2001CA1341308C Vaccines against avian herpes viruses
10/23/2001CA1341307C Nucleotide sequences of avian herpes viruses
10/18/2001WO2001077676A1 T2r taste receptors and genes encoding same
10/18/2001WO2001077663A1 Methods for screening and identifying host pathogen defense genes
10/18/2001WO2001077357A2 Chromosomal vectors and uses thereof
10/18/2001WO2001077343A1 MUIR-TORRE-LIKE SYNDROME INFhit DEFICIENT MICE
10/18/2001WO2001077335A2 Listeria monocytogenes genome, polypeptides and uses
10/18/2001WO2001076620A2 Use of vegf and homologues to treat neuron disorders
10/18/2001WO2001076361A1 Animal and cell models for type ii diabetes and their use
10/18/2001WO2001023525A3 Methods of producing cloned and transgenic mammals
10/18/2001WO2001020004A3 Protein phosphatase and kinase proteins
10/18/2001WO2000073460A3 Modified cytokine for its stabilisation
10/18/2001US20010032341 Modification of the expression of UDP-glucose 4-epimerase may result in grains with reduced fiber and increased levels of starch thus adding value for feed, food, and industrial applications of crops
10/18/2001US20010032340 Controlling offspring's sex ratio by targeting transgenes onto the sex chromosomes
10/18/2001US20010032337 Introduction of exogenous nucleotide sequences into a genome by microinjection of infectious retrovirus into the perivitelline space of the egg; making a bovine embryo; use to confer disease resistance, for example
10/18/2001DE10016083A1 Nicht-menschliches Tiermodell für Wachstumsdefizienz und Defekte der Informationsverarbeitung oder der kognitiven Funktion und seine Verwendung A non-human animal model for Wachstumsdefizienz and defects of the information processing or the cognitive function and its use
10/18/2001CA2659656A1 The use of vegf165 to treat neuron disorders
10/18/2001CA2654413A1 Use of vegf and homologues to treat neuron disorders
10/18/2001CA2414652A1 Animal and cell models for type ii diabetes and their use
10/18/2001CA2406366A1 Muir-torre-like syndrome infhit deficient mice
10/18/2001CA2404988A1 Listeria monocytogenes genome, polypeptides and uses
10/18/2001CA2404355A1 Methods for screening and identifying host pathogen defense genes
10/18/2001CA2403140A1 Novel chromosomal vectors and uses thereof
10/18/2001CA2403003A1 T2r taste receptors and genes encoding same
10/17/2001EP1146118A1 Organs for transplantation induced in vitro